Related Experiment Videos
Long-term results and clinical problems after portoenterostomy in patients with biliary atresia
1Department of Pediatric Surgery, Kyushu University School of Medicine, Fukuoka, Japan.
Insights
Biliary atresia treatment via Kasai
Area of Science:
- Pediatric Surgery
- Hepatology
- Gastroenterology
Background:
- Biliary atresia is a rare neonatal liver disease.
- Early diagnosis and surgical intervention are critical.
Purpose of the Study:
- To evaluate the long-term outcomes of Kasai's operation for biliary atresia.
- To identify factors influencing survival and complications.
Main Methods:
- Retrospective analysis of 71 biliary atresia cases operated between 1962-1986.
- Focus on 62 infants undergoing hepatic portoenterostomy (Kasai's operation).
Main Results:
- A 10-year survival rate of 22.5% was observed after Kasai's operation.
- Six patients had favorable outcomes (bilirubin < 1.0 mg/dL).
- Eight patients experienced complications (e.g., varices, jaundice) with higher bilirubin levels, one requiring liver transplant.
Conclusions:
- Kasai's operation offers a potential for long-term survival in biliary atresia.
- Close monitoring is crucial, especially for patients with elevated bilirubin levels post-surgery.
- Management strategies may need to be tailored based on post-operative bilirubin levels.
Abstract:
From January 1962 through December 1986, 71 cases of biliary atresia were operated on. Nine of these patients underwent only an exploratory laparotomy. A hepatic portoenterostomy (Kasai's operation) was performed on 62 infants with biliary atresia. Of these 62 children, 18 survived more than 10 years. However, 4 of the 18 died shortly thereafter because of persistent or recurrent jaundice and hepatic failure. Fourteen patients, however, are still alive more than ten years after portoenterostomy, today the actual 10-year survival rate is thus 22.5%. Six of them have no severe complications and their serum total bilirubin is less than 1.0 mg/dl. However, 8 patients, whose serum total bilirubin is more than 1.0 mg/dl, demonstrated numerous clinical problems such as esophageal varices, hypersplenism and recurrent jaundice after cholangitis. One of the patients in the latter group eventually underwent a liver transplantation because of the recurrent jaundice and hepatic insufficiency. In the treatment of biliary atresia, a close and careful follow-up is therefore essential especially for patients whose serum total bilirubin is more than 1.0 mg/dl.